Paul L Berns Eq Rx, Inc. (EQRX) insider trading activity

EQRX Quotes by TradingView

Paul L Berns is Director of EQRx, Inc.. Currently has a direct ownership of 0 shares of EQRX, which is worth approximately $0. The most recent transaction as insider was on Nov 09, 2023, when has been sold 627,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

PAUL L BERNS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 09 2023
SELL
Sale (or disposition) back to the issuer
-
627,000 Reduced 100.0%
0 Common Stock
Dec 17 2021
BUY
Grant, award, or other acquisition
-
627,000 Added 50.0%
627,000 Common Stock

Also insider at

JAZZ
Jazz Pharmaceuticals plc Healthcare
Director
UBX
Unity Biotechnology, Inc. Healthcare
NMRA
Neumora Therapeutics, Inc.
PLB

Paul L Berns

Director
Dublin 4, L2

Track Institutional and Insider Activities on EQRX

Follow EQRx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EQRX shares.

Notify only if

Insider Trading

Get notified when an Eq Rx, Inc. insider buys or sells EQRX shares.

Notify only if

News

Receive news related to EQRx, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EQRX